Pacific Biosciences Of California (PACB) Return on Invested Capital (2022 - 2024)
Pacific Biosciences Of California (PACB) posted quarterly Return on Invested Capital of 0.02% for Q2 2024, down 162.99% quarter-over-quarter from 0.01% in Q1 2024.
Pacific Biosciences Of California (PACB) Return on Invested Capital (2022 - 2024) Analysis & Trends
Pacific Biosciences Of California's Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.02% for Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 0.01% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 0.01% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 0.01% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 0.00% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 0.04% |
| 10 | Pacific Biosciences Of California | 394.53 Mn | 157.66 Mn | 12.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Sep 30, 2022 | -1.78% |